GKB Ophthalmics Ltd Financials
Company Logo

GKB Ophthalmics Ltd Financial Statement

GKB Ophthalmics Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue8.32
Operating Expense9.30
Net Profit-2.05
Net Profit Margin-24.64
Earning Per Share-4.07
EBIDTA-0.99
Effective Tax RateTBA
Invest in GKB Ophthalmics Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

GKB Ophthalmics Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual31.18
Operating Expenses Annual32.45
Operating Profit Annual0.80
Interest Annual1.59
Depreciation2.58
Net Profit Annual-3.42
Tax Annual0.04

GKB Ophthalmics Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.07
Cash Flow from Operations1.36
Cash Flow from Investing0.37
Cash Flow from Financing-1.74
Cash Flow at the End0.07

GKB Ophthalmics Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)2.57
PBIT Margin (%)-5.74
PBT Margin (%)-2.12
Net PROFIT Margin (%)-10.97
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-8.56
Total Debt / Equity (X)0.43
Asset Turnover Ratio (%)0.78

GKB Ophthalmics Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual15.89
Total Current Assets Annual14.26
Non Current Assets Annual34.14
Total Shareholders Funds Annual23.99
Total Assets Annual48.39

GKB Ophthalmics Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-2.41

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 23, 2024, GKB Ophthalmics Ltd has a market capitalization of 43.96 Cr. Value Research classifies it as a Micro-Cap company.
Yes, GKB Ophthalmics Ltd is debt-free with a debt-to-equity ratio of 0.46.
In FY 2023 , GKB Ophthalmics Ltd recorded a total revenue of approximately 31.18 Cr marking a significant milestone in the company's financial performance.
GKB Ophthalmics Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and 0.1% annually, respectively..
GKB Ophthalmics Ltd's current PE ratio is -12.85.
GKB Ophthalmics Ltd's ROCE averaged -3.7% from the FY ending March 2022 to 2024, with a median of -3.9%. It peaked at -2.3% in March 2022, reflecting strong capital efficiency over the period..
GKB Ophthalmics Ltd's latest EBIT is Rs. -1.79 Cr, surpassing the average EBIT of Rs. -1.43 Cr over the 5 years..